An autoclave is the pressurised chamber, which is primarily used in the process of sterilization, where medical equipment and supplies are sterilized at high pressure and temperature than the normal air pressure. Sterilization by autoclave was mostly applied in the field of microbiology, dentistry and medicines. After use of medical devices, they may get contaminated, because of that they need be autoclaved before every use for elimination of bacteria, viruses, fungi and other viable organisms. Many of the medical grade autoclaved are confined to run regulatory approved cycles. It is mostly operated on high pressure, steam and time, so they use high temperature and pressure steam for the purpose of sterilization.
The Asia Pacific pharmaceutical autoclave market is observing lucrative growth during forecast period of 2021 to 2027. The invention of portable steam autoclave and rising biohazardous waste generation in hospitals are the chief opportunities of the pharmaceutical autoclave market. The key factors such as stringent regulation by government toward healthy and sanitized policy in healthcare and pharmaceutical is boosting growth of Asia Pacific pharmaceutical autoclave market. The growing number of invasive surgeries and sophisticated sterilization technologies is propelling growth of Asia Pacific pharmaceutical autoclave market. However, lack of skilled professional workers is restraining growth of Asia Pacific pharmaceutical autoclave market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the deep brain stimulation devices market. In addition, complete analysis of changes on deep brain stimulation devices expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Asia Pacific economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The growing prevalence of COVID-19 is rising the demand of pharmaceutical autoclave market during the COVID-19 pandemics. The rising prevalence of infectious diseases is also projecting growth of pharmaceutical autoclave market during the COVID-19 pandemic. The rising cases of hospital acquired infectious is also boosting the growth pharmaceutical autoclave market during COVID-19 pandemic.
The Asia Pacific pharmaceutical autoclave market is segmented into the product type, capacity, technology, end user and country.
Product type like vertical, horizontal, table top, floor standing and high pressure are comprised in the Asia Pacific pharmaceutical autoclave market. In which vertical is also contributing in the growth of Asia Pacific pharmaceutical autoclave market. The high use of autoclave in various industries is propelling growth of Asia Pacific pharmaceutical market. The rising regulation regarding sterilization of equipment is also boosting growth of Asia Pacific pharmaceutical autoclave market.
Various capacity such as 50-200 L, 200-500 L, 500-1000 L, 1000-2000 L and >2000 L are comprised in the Asia Pacific pharmaceutical autoclave market. In which 50-200 L is also contributing in the growth of Asia Pacific pharmaceutical autoclave market. The high adoption of autoclave in healthcare industry is refuelling growth of Asia Pacific pharmaceutical autoclave market. The growing rate of hospital acquired infections is also propelling growth of Asia Pacific pharmaceutical autoclave market.
Technologies such as dry heat autoclave, steam autoclave, chemical solution autoclave and glass bead autoclave are comprised in the Asia Pacific pharmaceutical autoclave market. In which glass bead autoclave is also contributing in the growth of Asia Pacific pharmaceutical autoclave market. The rising adoption of autoclave in various microbiology labs is boosting growth of Asia Pacific pharmaceutical autoclave market. The rising incidence of hospital acquired infections is also boosting growth of Asia Pacific pharmaceutical Autoclave market.
End user such as pharmaceutical and healthcare industry, research centres and academic institutes are comprised in the Asia Pacific pharmaceutical autoclave market. In which research centre is also contributing to the growth of Asia Pacific pharmaceutical autoclave market. The rising research and development activities are boosting growth of Asia Pacific pharmaceutical autoclave market. The growing use of autoclave in the healthcare industry is also refuelling growth of Asia Pacific pharmaceutical autoclave market.
The Asia Pacific pharmaceutical autoclave market is studied for key countries like India, Australia, China, Japan and South Korea. In which China followed by India and Japan are anticipated to dominate the market in 2020. The rising research and development activities in healthcare is boosting growth of Asia Pacific pharmaceutical autoclave market. The growing cases of nosocomial infection is also boosting growth of Asia Pacific pharmaceutical autoclave market.
The major players operating in pharmaceutical autoclave market are Astell Scientific, Sakura Seiki Co.,Ltd., Microbiology International, Benchmark Scientific, Inc., Getinge Ab, Shinva Medical Instrument Co., Ltd, Belimed, Phc Holdings Corporation, Melag Medizintechnik Gmbh & Co. Kg, Amerex Instruments, Inc. and Zirbus Technology Gmbh among others.
The report analyses the pharmaceutical autoclave market by product type, capacity, technology, end user and country. Various product type such as vertical, horizontal, table top, floor standing and high pressure are comprised in the market. By capacity, the pharmaceutical autoclave market is segmented into 50-200 L, 200-500 L, 500-1000 L, 1000-2000 L and >2000 L. Based on technology, the market is segmented into the dry heat autoclave, steam autoclave, chemical solution autoclave and glass bead autoclave. Based on end users, the market is segmented into the pharmaceutical and healthcare industry, research centres and academic institutes. The report also analysed the impact of COVID-19 on the pharmaceutical autoclave market and it concludes that the growing prevalence of COVID-19 is rising the demand of pharmaceutical autoclave market during the COVID-19 pandemics. The rising prevalence of infectious diseases is also projecting growth of pharmaceutical autoclave market during the COVID-19 pandemic. The rising cases of hospital acquired infectious is also boosting the growth pharmaceutical autoclave market during COVID-19 pandemic. The report also analysed various key players operating in the regions.
Why to buy this report